KALARIS THERAPEUTICS, INC. Depreciation
KALARIS THERAPEUTICS, INC. (KLRS) reported Depreciation of $20.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-11
- KALARIS THERAPEUTICS, INC. depreciation for the quarter ending 2026-06-30 was $10.00K.
- KALARIS THERAPEUTICS, INC. depreciation for the quarter ending 2026-03-31 was $10.00K.
- KALARIS THERAPEUTICS, INC. depreciation for the quarter ending 2025-12-31 was $10.00K.
- KALARIS THERAPEUTICS, INC. depreciation for fiscal 2025 was $13.00K.
- KALARIS THERAPEUTICS, INC. depreciation for fiscal 2023 was $400.00K, a 42.86% decline from fiscal 2022.
- KALARIS THERAPEUTICS, INC. depreciation for fiscal 2022 was $700.00K, a 250.00% increase from fiscal 2021.
- KALARIS THERAPEUTICS, INC. depreciation for fiscal 2021 was $200.00K, a 100.00% increase from fiscal 2020.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $20.00K 10-Q · filed 2026-08-11 | $30.00K derived: sum of 3 quarters · filed 2026-08-11 | |
| 2026-03-31 | $10.00K 10-Q · filed 2026-05-12 | $20.00K derived: sum of 2 quarters · filed 2026-05-12 | ||
| 2025-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $13.00K 10-K · filed 2026-03-17 | ||
| 2025-09-30 | $3.00K 10-Q · filed 2025-11-12 | |||
| 2023-12-31 | $400.00K 10-K · filed 2024-03-15 | |||
| 2022-12-31 | $700.00K 10-K · filed 2024-03-15 | |||
| 2021-12-31 | $200.00K 10-K · filed 2023-02-15 | |||
| 2020-12-31 | $100.00K 10-K · filed 2022-02-10 | |||
| 2019-12-31 | $19.00K 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |